APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phentolamine Mesylate Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Phentolamine Mesylate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025184 pages

Choose your research edition.

Industry ResearchPhentolamine Mesylate Injection Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Phentolamine Mesylate Injection Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Phentolamine Mesylate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phentolamine Mesylate Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Phentolamine Mesylate Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Phentolamine Mesylate Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Phentolamine Mesylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Phentolamine Mesylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Phentolamine Mesylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Phentolamine Mesylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Phentolamine Mesylate Injection include Hikma, Precision Dose, Septodont, Hainan Poly Pharm, CR Double-Crane, Sunflower Pharmaceutical, Shanghai Fudan Forward Pharmaceuticals and Sichuan Meida Kangjiale Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Phentolamine Mesylate Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Phentolamine Mesylate Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Phentolamine Mesylate Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Phentolamine Mesylate Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Phentolamine Mesylate Injection Segment by Company

Hikma

Precision Dose

Septodont

Hainan Poly Pharm

CR Double-Crane

Sunflower Pharmaceutical

Shanghai Fudan Forward Pharmaceuticals

Sichuan Meida Kangjiale Pharmaceutical

Phentolamine Mesylate Injection Segment by Type

Intravenous Injection

Intramuscular Injection

Phentolamine Mesylate Injection Segment by Application

Hospital and Clinic

Pharmacy

Other

Phentolamine Mesylate Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phentolamine Mesylate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phentolamine Mesylate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phentolamine Mesylate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Phentolamine Mesylate Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Phentolamine Mesylate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Phentolamine Mesylate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Phentolamine Mesylate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Phentolamine Mesylate Injection Industry Trends Table 2. Phentolamine Mesylate Injection Industry Drivers Table 3. Phentolamine Mesylate Injection Industry Opportunities and Challenges Table 4. Phentolamine Mesylate Injection Industry Restraints Table 5. Global Phentolamine Mesylate Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Phentolamine Mesylate Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Phentolamine Mesylate Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Phentolamine Mesylate Injection Sales Market Share by Manufacturers Table 9. Global Phentolamine Mesylate Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Phentolamine Mesylate Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Phentolamine Mesylate Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Phentolamine Mesylate Injection Manufacturers, Product Type & Application Table 13. Global Phentolamine Mesylate Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Phentolamine Mesylate Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Intravenous Injection Table 17. Major Manufacturers of Intramuscular Injection Table 18. Global Phentolamine Mesylate Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Phentolamine Mesylate Injection Sales by Type (2021-2026) & (K Units) Table 20. Global Phentolamine Mesylate Injection Sales by Type (2027-2032) & (K Units) Table 21. Global Phentolamine Mesylate Injection Sales Market Share by Type (2021-2026) Table 22. Global Phentolamine Mesylate Injection Sales Market Share by Type (2027-2032) Table 23. Global Phentolamine Mesylate Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Phentolamine Mesylate Injection Revenue by Type (2021-2026) & (K Units) Table 25. Global Phentolamine Mesylate Injection Revenue by Type (2027-2032) & (K Units) Table 26. Global Phentolamine Mesylate Injection Revenue Market Share by Type (2021-2026) Table 27. Global Phentolamine Mesylate Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital and Clinic Table 29. Major Manufacturers of Pharmacy Table 30. Major Manufacturers of Other Table 31. Global Phentolamine Mesylate Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Phentolamine Mesylate Injection Sales by Application (2021-2026) & (K Units) Table 33. Global Phentolamine Mesylate Injection Sales by Application (2027-2032) & (K Units) Table 34. Global Phentolamine Mesylate Injection Sales Market Share by Application (2021-2026) Table 35. Global Phentolamine Mesylate Injection Sales Market Share by Application (2027-2032) Table 36. Global Phentolamine Mesylate Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Phentolamine Mesylate Injection Revenue by Application (2021-2026) & (K Units) Table 38. Global Phentolamine Mesylate Injection Revenue by Application (2027-2032) & (K Units) Table 39. Global Phentolamine Mesylate Injection Revenue Market Share by Application (2021-2026) Table 40. Global Phentolamine Mesylate Injection Revenue Market Share by Application (2027-2032) Table 41. Global Phentolamine Mesylate Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Phentolamine Mesylate Injection Sales by Region (2021-2026) & (K Units) Table 43. Global Phentolamine Mesylate Injection Sales Market Share by Region (2021-2026) Table 44. Global Phentolamine Mesylate Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Phentolamine Mesylate Injection Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Phentolamine Mesylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Phentolamine Mesylate Injection Sales by Country (2021-2026) & (K Units) Table 48. North America Phentolamine Mesylate Injection Sales by Country (2027-2032) & (K Units) Table 49. Europe Phentolamine Mesylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Phentolamine Mesylate Injection Sales by Country (2021-2026) & (K Units) Table 51. Europe Phentolamine Mesylate Injection Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Phentolamine Mesylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Phentolamine Mesylate Injection Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Phentolamine Mesylate Injection Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Phentolamine Mesylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Phentolamine Mesylate Injection Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Phentolamine Mesylate Injection Sales by Country (2027-2032) & (K Units) Table 58. Global Phentolamine Mesylate Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Phentolamine Mesylate Injection Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Phentolamine Mesylate Injection Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Phentolamine Mesylate Injection Revenue Market Share by Region (2021-2026) Table 62. Global Phentolamine Mesylate Injection Revenue Market Share by Region (2027-2032) Table 63. Hikma Company Information Table 64. Hikma Business Overview Table 65. Hikma Phentolamine Mesylate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Hikma Phentolamine Mesylate Injection Product Portfolio Table 67. Hikma Recent Development Table 68. Precision Dose Company Information Table 69. Precision Dose Business Overview Table 70. Precision Dose Phentolamine Mesylate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Precision Dose Phentolamine Mesylate Injection Product Portfolio Table 72. Precision Dose Recent Development Table 73. Septodont Company Information Table 74. Septodont Business Overview Table 75. Septodont Phentolamine Mesylate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Septodont Phentolamine Mesylate Injection Product Portfolio Table 77. Septodont Recent Development Table 78. Hainan Poly Pharm Company Information Table 79. Hainan Poly Pharm Business Overview Table 80. Hainan Poly Pharm Phentolamine Mesylate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Hainan Poly Pharm Phentolamine Mesylate Injection Product Portfolio Table 82. Hainan Poly Pharm Recent Development Table 83. CR Double-Crane Company Information Table 84. CR Double-Crane Business Overview Table 85. CR Double-Crane Phentolamine Mesylate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. CR Double-Crane Phentolamine Mesylate Injection Product Portfolio Table 87. CR Double-Crane Recent Development Table 88. Sunflower Pharmaceutical Company Information Table 89. Sunflower Pharmaceutical Business Overview Table 90. Sunflower Pharmaceutical Phentolamine Mesylate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Sunflower Pharmaceutical Phentolamine Mesylate Injection Product Portfolio Table 92. Sunflower Pharmaceutical Recent Development Table 93. Shanghai Fudan Forward Pharmaceuticals Company Information Table 94. Shanghai Fudan Forward Pharmaceuticals Business Overview Table 95. Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Product Portfolio Table 97. Shanghai Fudan Forward Pharmaceuticals Recent Development Table 98. Sichuan Meida Kangjiale Pharmaceutical Company Information Table 99. Sichuan Meida Kangjiale Pharmaceutical Business Overview Table 100. Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Product Portfolio Table 102. Sichuan Meida Kangjiale Pharmaceutical Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Phentolamine Mesylate Injection Distributors List Table 106. Phentolamine Mesylate Injection Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Phentolamine Mesylate Injection Product Image Figure 2. Global Phentolamine Mesylate Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Phentolamine Mesylate Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Phentolamine Mesylate Injection Sales (2021-2032) & (K Units) Figure 5. Global Phentolamine Mesylate Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Phentolamine Mesylate Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Intravenous Injection Image Figure 9. Intramuscular Injection Image Figure 10. Global Phentolamine Mesylate Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Phentolamine Mesylate Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Phentolamine Mesylate Injection Sales Market Share by Type (2021-2032) Figure 13. Global Phentolamine Mesylate Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Phentolamine Mesylate Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Phentolamine Mesylate Injection Revenue Market Share by Type (2021-2032) Figure 16. Hospital and Clinic Image Figure 17. Pharmacy Image Figure 18. Other Image Figure 19. Global Phentolamine Mesylate Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Phentolamine Mesylate Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Phentolamine Mesylate Injection Sales Market Share by Application (2021-2032) Figure 22. Global Phentolamine Mesylate Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Phentolamine Mesylate Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Phentolamine Mesylate Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Phentolamine Mesylate Injection Sales Market Share by Country (2021-2032) Figure 27. U.S. Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Phentolamine Mesylate Injection Sales Market Share by Country (2021-2032) Figure 32. Germany Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Phentolamine Mesylate Injection Sales Market Share by Country (2021-2032) Figure 39. China Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Phentolamine Mesylate Injection Sales Market Share by Country (2021-2032) Figure 47. Brazil Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Phentolamine Mesylate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Phentolamine Mesylate Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Phentolamine Mesylate Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Phentolamine Mesylate Injection Revenue (2021-2032) & (US$ Million) Figure 58. North America Phentolamine Mesylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Phentolamine Mesylate Injection Revenue (2021-2032) & (US$ Million) Figure 60. Europe Phentolamine Mesylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Phentolamine Mesylate Injection Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Phentolamine Mesylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Phentolamine Mesylate Injection Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Phentolamine Mesylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Phentolamine Mesylate Injection Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Phentolamine Mesylate Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Intravenous Injection
  • Intramuscular Injection
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Hikma
  • Precision Dose
  • Septodont
  • Hainan Poly Pharm
  • CR Double-Crane
  • Sunflower Pharmaceutical
  • Shanghai Fudan Forward Pharmaceuticals
  • Sichuan Meida Kangjiale Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Phentolamine Mesylate Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Phentolamine Mesylate Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Phentolamine Mesylate Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Phentolamine Mesylate Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Phentolamine Mesylate Injection Market Dynamics
  1. 2.1 Phentolamine Mesylate Injection Industry Trends
  2. 2.2 Phentolamine Mesylate Injection Industry Drivers
  3. 2.3 Phentolamine Mesylate Injection Industry Opportunities and Challenges
  4. 2.4 Phentolamine Mesylate Injection Industry Restraints
3 Phentolamine Mesylate Injection Market by Manufacturers
  1. 3.1 Global Phentolamine Mesylate Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Phentolamine Mesylate Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Phentolamine Mesylate Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Phentolamine Mesylate Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Phentolamine Mesylate Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Phentolamine Mesylate Injection Manufacturers, Product Type & Application
  7. 3.7 Global Phentolamine Mesylate Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Phentolamine Mesylate Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Phentolamine Mesylate Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Phentolamine Mesylate Injection Tier 1, Tier 2, and Tier 3
4 Phentolamine Mesylate Injection Market by Type
  1. 4.1 Phentolamine Mesylate Injection Type Introduction
  2. 4.1.1 Intravenous Injection
  3. 4.1.2 Intramuscular Injection
  4. 4.2 Global Phentolamine Mesylate Injection Sales by Type
  5. 4.2.1 Global Phentolamine Mesylate Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Phentolamine Mesylate Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Phentolamine Mesylate Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Phentolamine Mesylate Injection Revenue by Type
  9. 4.3.1 Global Phentolamine Mesylate Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Phentolamine Mesylate Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Phentolamine Mesylate Injection Revenue Market Share by Type (2021-2032)
5 Phentolamine Mesylate Injection Market by Application
  1. 5.1 Phentolamine Mesylate Injection Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Phentolamine Mesylate Injection Sales by Application
  6. 5.2.1 Global Phentolamine Mesylate Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Phentolamine Mesylate Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Phentolamine Mesylate Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Phentolamine Mesylate Injection Revenue by Application
  10. 5.3.1 Global Phentolamine Mesylate Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Phentolamine Mesylate Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Phentolamine Mesylate Injection Revenue Market Share by Application (2021-2032)
6 Global Phentolamine Mesylate Injection Sales by Region
  1. 6.1 Global Phentolamine Mesylate Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Phentolamine Mesylate Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Phentolamine Mesylate Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Phentolamine Mesylate Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Phentolamine Mesylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Phentolamine Mesylate Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Phentolamine Mesylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Phentolamine Mesylate Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Phentolamine Mesylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Phentolamine Mesylate Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Phentolamine Mesylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Phentolamine Mesylate Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Phentolamine Mesylate Injection Revenue by Region
  1. 7.1 Global Phentolamine Mesylate Injection Revenue by Region
  2. 7.1.1 Global Phentolamine Mesylate Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Phentolamine Mesylate Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Phentolamine Mesylate Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Phentolamine Mesylate Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Phentolamine Mesylate Injection Revenue (2021-2032)
  8. 7.2.2 North America Phentolamine Mesylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Phentolamine Mesylate Injection Revenue (2021-2032)
  11. 7.3.2 Europe Phentolamine Mesylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Phentolamine Mesylate Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Phentolamine Mesylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Phentolamine Mesylate Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Phentolamine Mesylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Hikma
  2. 8.1.1 Hikma Company Information
  3. 8.1.2 Hikma Business Overview
  4. 8.1.3 Hikma Phentolamine Mesylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Hikma Phentolamine Mesylate Injection Product Portfolio
  6. 8.1.5 Hikma Recent Developments
  7. 8.2 Precision Dose
  8. 8.2.1 Precision Dose Company Information
  9. 8.2.2 Precision Dose Business Overview
  10. 8.2.3 Precision Dose Phentolamine Mesylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Precision Dose Phentolamine Mesylate Injection Product Portfolio
  12. 8.2.5 Precision Dose Recent Developments
  13. 8.3 Septodont
  14. 8.3.1 Septodont Company Information
  15. 8.3.2 Septodont Business Overview
  16. 8.3.3 Septodont Phentolamine Mesylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Septodont Phentolamine Mesylate Injection Product Portfolio
  18. 8.3.5 Septodont Recent Developments
  19. 8.4 Hainan Poly Pharm
  20. 8.4.1 Hainan Poly Pharm Company Information
  21. 8.4.2 Hainan Poly Pharm Business Overview
  22. 8.4.3 Hainan Poly Pharm Phentolamine Mesylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hainan Poly Pharm Phentolamine Mesylate Injection Product Portfolio
  24. 8.4.5 Hainan Poly Pharm Recent Developments
  25. 8.5 CR Double-Crane
  26. 8.5.1 CR Double-Crane Company Information
  27. 8.5.2 CR Double-Crane Business Overview
  28. 8.5.3 CR Double-Crane Phentolamine Mesylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CR Double-Crane Phentolamine Mesylate Injection Product Portfolio
  30. 8.5.5 CR Double-Crane Recent Developments
  31. 8.6 Sunflower Pharmaceutical
  32. 8.6.1 Sunflower Pharmaceutical Company Information
  33. 8.6.2 Sunflower Pharmaceutical Business Overview
  34. 8.6.3 Sunflower Pharmaceutical Phentolamine Mesylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sunflower Pharmaceutical Phentolamine Mesylate Injection Product Portfolio
  36. 8.6.5 Sunflower Pharmaceutical Recent Developments
  37. 8.7 Shanghai Fudan Forward Pharmaceuticals
  38. 8.7.1 Shanghai Fudan Forward Pharmaceuticals Company Information
  39. 8.7.2 Shanghai Fudan Forward Pharmaceuticals Business Overview
  40. 8.7.3 Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Product Portfolio
  42. 8.7.5 Shanghai Fudan Forward Pharmaceuticals Recent Developments
  43. 8.8 Sichuan Meida Kangjiale Pharmaceutical
  44. 8.8.1 Sichuan Meida Kangjiale Pharmaceutical Company Information
  45. 8.8.2 Sichuan Meida Kangjiale Pharmaceutical Business Overview
  46. 8.8.3 Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Product Portfolio
  48. 8.8.5 Sichuan Meida Kangjiale Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Phentolamine Mesylate Injection Value Chain Analysis
  2. 9.1.1 Phentolamine Mesylate Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Phentolamine Mesylate Injection Production Mode & Process
  6. 9.2 Phentolamine Mesylate Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Phentolamine Mesylate Injection Distributors
  9. 9.2.3 Phentolamine Mesylate Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst